India on Russia vaccine site list
(World News Russia)

Two Russian entities have named India among several sites for planned large-scale efficacy trials and mass production of a candidate coronavirus vaccine that has been approved by Russian regulators without the crucial final round of tests. But health officials in New Delhi have signalled that India is not ready yet for the trials and the mass production. The Gamaleya National Centre that developed the vaccine and Russia’s sovereign wealth fund have said on a website on the vaccine that they plan to conduct the large-scale “Phase 3” clinical trials in Brazil, India, the Philippines, Saudi Arabia and the United Arab Emirates. The Gamaleya centre and the Russia Direct...